Literature DB >> 18758150

Changes of the peptide YY levels in the intestinal tissue of rats with experimental colitis following oral administration of mesalazine and prednisolone.

Yoshihiko Hirotani1, Kyoko Mikajiri, Kenji Ikeda, Michiaki Myotoku, Nobuo Kurokawa.   

Abstract

Few studies have reported the changes in the peptide YY (PYY) levels in the intestinal tissue of rats with ulcerative colitis (UC) following oral administration of mesalazine and prednisolone. We investigated the effects of these drugs on the intestinal mucosal PYY levels in a rat model of UC. We confirmed that the PYY levels in the rat intestinal mucosal tissue were high in the lower intestinal tract. The leukocyte count and hemoglobin levels approached the normal values after administering mesalazine or prednisolone to rats treated with 3% dextran sulfate sodium (DSS). The PYY levels in the caecum and colon decreased significantly after administering DSS but increased when mesalazine was administered in a tissue-specific manner. Unlike mesalazine, the PYY levels increased in the ileum in addition to the colon and rectum after administering prednisolone. However, neither of the drugs induced any changes in the plasma PYY levels. These findings indicate that changes in the intestinal tissue PYY levels may be partially involved in the improvement of DSS-induced UC in rats following the administration of these drugs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18758150     DOI: 10.1248/yakushi.128.1347

Source DB:  PubMed          Journal:  Yakugaku Zasshi        ISSN: 0031-6903            Impact factor:   0.302


  15 in total

Review 1.  Enteroendocrine cells-sensory sentinels of the intestinal environment and orchestrators of mucosal immunity.

Authors:  J J Worthington; F Reimann; F M Gribble
Journal:  Mucosal Immunol       Date:  2017-08-30       Impact factor: 7.313

2.  High densities of serotonin and peptide YY cells in the colon of patients with lymphocytic colitis.

Authors:  Magdy El-Salhy; Doris Gundersen; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  World J Gastroenterol       Date:  2012-11-14       Impact factor: 5.742

3.  Sex-dependent control of murine emotional-affective behaviour in health and colitis by peptide YY and neuropeptide Y.

Authors:  Evelin Painsipp; Herbert Herzog; Günther Sperk; Peter Holzer
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

Review 4.  The homeostatic role of neuropeptide Y in immune function and its impact on mood and behaviour.

Authors:  A Farzi; F Reichmann; P Holzer
Journal:  Acta Physiol (Oxf)       Date:  2015-01-09       Impact factor: 6.311

Review 5.  Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut-brain axis.

Authors:  Peter Holzer; Florian Reichmann; Aitak Farzi
Journal:  Neuropeptides       Date:  2012-09-11       Impact factor: 3.286

6.  Si Shen Wan Regulates Phospholipase Cγ-1 and PI3K/Akt Signal in Colonic Mucosa from Rats with Colitis.

Authors:  Duan-Yong Liu; Rong Xu; Min-Fang Huang; Hong-Yan Huang; Xin Wang; Yong Zou; Hai-Yang Yue; Hai-Mei Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2015-07-27       Impact factor: 2.629

Review 7.  The role of peptide YY in gastrointestinal diseases and disorders (review).

Authors:  Magdy El-Salhy; Tarek Mazzawi; Doris Gundersen; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  Int J Mol Med       Date:  2012-12-21       Impact factor: 4.101

8.  Enteroendocrine cells, stem cells and differentiation progenitors in rats with TNBS-induced colitis.

Authors:  Magdy El-Salhy; Tarek Mazzawi; Kazuo Umezawa; Odd Helge Gilja
Journal:  Int J Mol Med       Date:  2016-10-24       Impact factor: 4.101

Review 9.  Neuropeptides and the microbiota-gut-brain axis.

Authors:  Peter Holzer; Aitak Farzi
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

10.  Treatment with novel AP-1 and NF-κB inhibitors restores the colonic endocrine cells to normal levels in rats with DSS-induced colitis.

Authors:  Magdy El-Salhy; Kazuo Umezawa
Journal:  Int J Mol Med       Date:  2016-02-05       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.